Clinical Trials Directory

Trials / Unknown

UnknownNCT00665587

AMAZING PRAGUE (PRAGUE-12)

Surgical Treatment of Atrial Fibrillation - Prospective Randomized Study

Status
Unknown
Phase
Study type
Observational
Enrollment
220 (estimated)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim of the project is to assess the long-time clinical impact of surgical ablation (MAZE procedure) on patients who suffer from atrial fibrillation but are indicated to a cardiac surgery for other predominant cardiac diagnosis (heart valve surgery, coronary revascularization or combined surgery). In recent years, those patients are more and more frequently indicated to some type of MAZE procedure, without the real benefit of this procedure for patients has been assessed with an enough large, randomized study. Even though it is well known, that MAZE procedures declines the early postoperative incidence of atrial fibrillation, convincing data about its mid-term and long-term impact on patients and about the appearance of recidives of atrial fibrillation in long-time horizon are still missing. Our hypothesis assumes, that MAZE procedure will significantly decrease the appearance of atrial fibrillation one year after the operation, without increasing mortality or incidence of serious postoperative complications in thirty postoperative days.

Conditions

Interventions

TypeNameDescription
PROCEDURECox-MAZE IIIMaze procedure according to standards of the department

Timeline

Start date
2007-06-01
Primary completion
2009-06-01
Completion
2012-06-01
First posted
2008-04-24
Last updated
2008-04-24

Locations

3 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT00665587. Inclusion in this directory is not an endorsement.